Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib with Docetaxel and Prednisone in mCRPC
NCT02494921Phase 2Completed
- Sponsor
- Rahul Aggarwal
- Start
- Nov 2015
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ribociclib in prostate cancer (PCa), sponsored by Rahul Aggarwal. Started Nov 2015; status: completed.
02
Drugs
ribociclib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02494921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494921.